Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Long-Term Investments: 2011

Historic Long-Term Investments for Vanda Pharmaceuticals (VNDA) over the last 1 years, with Dec 2011 value amounting to $19.0 million.

  • Vanda Pharmaceuticals' Long-Term Investments was N/A to $61.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $61.8 million, marking a year-over-year change of. This contributed to the annual value of $19.0 million for FY2011, which is N/A change from last year.
  • As of FY2011, Vanda Pharmaceuticals' Long-Term Investments stood at $19.0 million.
  • In the past 5 years, Vanda Pharmaceuticals' Long-Term Investments registered a high of $19.0 million during FY2011, and its lowest value of $19.0 million during FY2011.
  • Moreover, its 1-year median value for Long-Term Investments was $19.0 million (2011), whereas its average is $19.0 million.